However, its risk-benefit profile is still unclear at this stage, which is why it is not approved by the FDA
FDA procedurally removed it from Category 2 in April 2026 after nominators withdrew their submissions and referred it to the Pharmacy Compounding Advisory Committee, which is scheduled to review it on July 23-24, 2026 for possible inclusion on the approved 503A bulks list
BPC-157 also plays a role in reducing inflammation and pain after surgery, which can be crucial for patients looking to recover as comfortably as possible
AOD-9604 $49.99 AOD-9604 is a growth hormone fragment studied for selective fat metabolism without affecting growth or insulin pathways
Lipo B12 Shots and MIC B12 Injections in La Grange If your goal is weight loss support, ask our team about lipo B12 shots , sometimes called MIC B12 injections
Is there anyone on injections and breastfeeding